Preclinical Development of a Lentiviral Vector for Gene Therapy of X-Linked Severe Combined Immunodeficiency - Université d'Évry Access content directly
Journal Articles Molecular Therapy - Methods and Clinical Development Year : 2018

Preclinical Development of a Lentiviral Vector for Gene Therapy of X-Linked Severe Combined Immunodeficiency

Fichier principal
Vignette du fichier
1-s2.0-S2329050118300263-main.pdf (1.72 Mo) Télécharger le fichier
Origin Publisher files allowed on an open archive

Dates and versions

hal-02178311 , version 1 (05-12-2023)

Identifiers

Cite

Valentina Poletti, Sabine Charrier, Guillaume Corre, Bernard Gjata, Alban Vignaud, et al.. Preclinical Development of a Lentiviral Vector for Gene Therapy of X-Linked Severe Combined Immunodeficiency. Molecular Therapy - Methods and Clinical Development, 2018, 9, pp.257-269. ⟨10.1016/j.omtm.2018.03.002⟩. ⟨hal-02178311⟩
45 View
4 Download

Altmetric

Share

Gmail Mastodon Facebook X LinkedIn More